This case underscores the importance of vigilant monitoring of unusual dermatologic manifestations in patients undergoing anti-TNF-α treatment, particularly because such adverse effects can lead to significant morbidity and may be associated with an increased risk of cutaneous squamous cell carcinoma. The gene discussed is TNF; the disease is cutaneous squamous cell carcinoma.